Oral mucosal melanoma treated with carbon ion radiotherapy: a case report

J Med Case Rep. 2016 Oct 18;10(1):284. doi: 10.1186/s13256-016-1071-8.

Abstract

Background: Oral mucosal melanoma is a rare disease with a relatively poor prognosis. Carbon ion radiotherapy has been shown to be effective against radiotherapy-resistant tumors owing to its excellent dose concentration and high biological effect.

Case presentation: Our patient was a 66-year-old Japanese man with oral mucosal melanoma of his right maxillary gingiva (T4aN0M0). He received carbon ion radiotherapy at 57.6 Gy (relative biological effectiveness) in 16 fractions for 4 weeks. Concomitant chemotherapy (dacarbazine + nimustine + vincristine) was administered at the same time as carbon ion radiotherapy initiation. Two courses of adjuvant chemotherapy were given after carbon ion radiotherapy. Although he experienced grade 2 acute oral mucositis, his symptoms improved within a few weeks of undergoing carbon ion radiotherapy. He was alive at the time of reporting, 35 months after treatment, without any recurrence. Late toxicity has not been observed.

Conclusions: Carbon ion radiotherapy for oral mucosal melanoma resulted in a good local effect.

Keywords: Carbon ion radiotherapy; Concomitant chemotherapy; Head and neck tumor; Oral mucosal melanoma.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Antineoplastic Agents, Phytogenic / administration & dosage*
  • Combined Modality Therapy
  • Dacarbazine / administration & dosage
  • Heavy Ion Radiotherapy* / adverse effects
  • Heavy Ion Radiotherapy* / methods
  • Humans
  • Male
  • Melanoma / pathology
  • Melanoma / radiotherapy*
  • Mouth Mucosa / pathology*
  • Mouth Mucosa / radiation effects
  • Mouth Neoplasms / pathology
  • Mouth Neoplasms / radiotherapy*
  • Mucous Membrane / pathology
  • Mucous Membrane / radiation effects
  • Neoplasm Recurrence, Local / prevention & control*
  • Nimustine / administration & dosage
  • Radiation Injuries / pathology*
  • Radiotherapy Dosage
  • Treatment Outcome
  • Vincristine / administration & dosage

Substances

  • Antineoplastic Agents, Phytogenic
  • Nimustine
  • Vincristine
  • Dacarbazine